Explore how proteomics supports pre-symptomatic disease detection, from mass spectrometry advances to multi-omics models and clinical validation challenges.

To read the first article of the series, where JEC Composites Magazine spoke with the consortium to describe the motivations behind r-LightBioCom and the foundations of its multi-disciplinary approach ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...

The second Society of Nuclear Medicine and Molecular Imaging (SNMMI) AI Summit, organized by the SNMMI AI Task Force, took ...

A new study suggests that artificial intelligence, also known as AI, may offer a better solution. Scientists have developed a ...

GPT-5.4 is out now on ChatGPT (where it goes by the name GPT-5.4 Thinking) as well as on the OpenAI API and OpenAI’s coding ...

Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...

Adam Christman, DVM, MBA: A long those lines, another misconception is that all toxin ingestions need to be hospitalized. Now, some of these can be done outpatient wise, and maybe through a ...

In the Gemini app and on the website, Nano Banana 2 will be the image generator for the Fast, Thinking, and Pro settings. It’s possible there will eventually be a Nano Banana 2 Pro—Google tends to ...

OpenAI's new GPT-5.4 clobbers humans on pro-level work in tests - by 83% ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...